As AI coding services face a reckoning, Bolt tries to go beyond building
StackBlitz runs a popular AI coding service called Bolt.new, and on Thursday the startup rolled out new features and an updated subscription aimed at keeping customers engaged on its platform for longer, Business Insider learned exclusively.
In the crowded AI coding market, many startups rely on reselling AI inference. They pay for access to AI models from frontier labs and Big Tech providers, then charge customers for their bespoke coding services — hoping to make a profit on the difference.
However, once users finish building a project, there's less reason to stick around. That increases the chance that some customers cancel their subscriptions.
Simons is seeing churn rates across the AI coding market running at 20% to 40%. He declined to say what Bolt's churn rate is; however, he noted that Wix, a more traditional website-building service, has much lower churn rates. That's because Wix generates the bulk of its recurring revenue from hosting and similar stickier offerings, rather than one-off project creation.
"This is the problem across all these companies right now. The churn rate for everyone is really high," Simons said. "You have to build a retentive business."
Love Business Insider? Log into Google and make us a preferred source.
Adding more valuable, stickier services on top of these models is the goal now, and Simons is repositioning Bolt with a new mantra, "Build Without Boundaries."
"The challenge here is that if your business is purely AI, reselling AI inference, your business is very fragile and vulnerable, because the winds can shift violently," Simons added.
One solution is to offer a broader array of tools that bring more users into your ecosystem.
This is why Bolt launched a subscription overhaul on Thursday aimed at making the service more of an end-to-end platform, not just a building tool.
Pricing will remain the same for most tiers, with only the entry-level plan rising from $20 to $25 a month. Every plan will now include hosting, domains, databases, serverless functions, authentication, SEO optimization, Stripe-powered payments, and analytics for an unlimited number of projects.
Bolt is partnering with companies such as infrastructure leader Netlify and database provider Supabase to provide the same scale and reliability used by major tech companies, but wrapped into one subscription.
The idea is to keep users in the Bolt ecosystem well past the initial creation phase. Instead of exporting their projects to another host or backend service, users can launch, run, and scale them without leaving the Bolt platform. Pay-as-you-go pricing will kick in only for unusually high traffic, with user-set caps to avoid surprise bills, Simons told Business Insider.
Simons sees this approach resonating with two main audiences: "prosumers," solo builders and entrepreneurs launching new products; and B2B product teams that use Bolt for rapid prototyping and internal tools. For the latter, staying in Bolt isn't just convenient; it embeds the platform into their ongoing workflow, making it harder to leave.
By going "beyond building" and integrating the entire product lifecycle into one subscription, Simons hopes to shift Bolt from being a one-off AI tool to an essential part of its customers' day-to-day operations.
Indeed, other AI coding services, Replit and Lovable, offering extra features now too, such as hosting.
In an industry where the winds can change fast, the bet is that offering a complete, durable ecosystem is the only way to scale sustainably.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Business Insider
3 hours ago
- Business Insider
Robinhood's CEO says he has a group of 150 top employees he'd rebuild the company with if something 'apocalyptic' happened
The criteria to get into Robinhood's founders club: Be among the 150 best-performing people at the company. In an episode of the "Cheeky Pint" podcast published on Wednesday, Robinhood's CEO Vlad Tenev said he has created a community of the best people across the company to ensure he is not just interacting with direct reports. "When I induct people into this community, I usually give a spiel," he said. "If there was a disaster or some kind of apocalyptic scenario, and we had to rebuild Robinhood with 150 people, you would be in that group." Tenev, who cofounded the company in 2013, said the founder community was initially compensation-focused and a way of awarding budgets to the best performers. But it has since become an "actual community" at the stock trading company. "I go through the updated strategy or vision, we get those folks together, we get their feedback," he said. "We do events. We have events in each city, and we get them together for dinners." Robinhood went public in 2021 and is now worth about $98.4 billion. It had 2,300 full-time employees as of December 2024. Tenev said he didn't want the group to become 150 people "at the top of the org chart," and includes people who have the most impact at every level of the company. The CEO added that the company "very much" concentrates promotions within top performers and rewards the "best people in the company" very well. Robinhood declined further comment to Business Insider. Tenev isn't the first to launch a secretive, invite-only company club. In 2011, Fortune reported that Apple had an exclusive club for top performers called the Top 100. It was described as an invitation-only, off-site meeting held for the 100 most influential people at Apple, regardless of their official position or tenure. Employees participated in a three-day strategy session focused on top-secret projects and how upcoming products will be unveiled. Apple did not respond to a comment asking if these off-sites or similar events for top employees still take place at the company.


Business Insider
3 hours ago
- Business Insider
What Behind the Jaw-Dropping 556% Rally in Bolt Projects Stock (BSLK)?
Materials-solutions company Bolt Projects Holdings (BSLK) stunned the market with a jaw-dropping 550% surge in its stock price on Wednesday. The rally was fueled by exceptional Q2 2025 results and upbeat growth forecasts. Nonetheless, the stock reversed some of its gains, falling over 28% in pre-market trading on Thursday. Year-to-date, BSLK shares are still up 48.5%. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. What Does Bolt Projects Holdings Do? Bolt Projects is a biomaterials company that creates innovative solutions for the beauty and personal care industry. Its Vegan Silk Technology Platform creates eco-friendly silk alternatives from plant-based or bio-engineered sources rather than silkworms. Bolt Projects Reports Massive Sales Growth In Q2, Bolt Projects' revenue soared more than 2,200% year-over-year to $1.3 million. The company also narrowed its net loss to $4.6 million, a sharp improvement from the $58.9 million loss reported a year ago. Additionally, Bolt achieved a positive gross margin, posting a gross profit of $62,000 versus a $29,000 gross loss in the same quarter last year. What Lies Ahead for Bolt Projects? Bolt Projects' recent growth has been fueled largely by surging demand for its Vegan Silk Technology Platform. CEO Dan Widmaier stated that the platform offers high-performance, eco-friendly benefits that meet customer needs and set the company up for long-term growth. Bolt's Vegan Silk is already attracting interest from major beauty players. A global skincare brand, owned by one of the world's top seven beauty conglomerates, plans to launch its first product featuring Vegan Silk in 2026, with additional products already in the pipeline. Such partnerships signal a growing shift in the industry toward sustainable ingredients, where Bolt has a clear competitive advantage. Looking ahead, Bolt has, for the first time, added gross profit projections to its financial guidance. The company expects at least $500,000 in gross profit in 2025 and $1 million in 2026, alongside minimum revenue targets of $4.5 million and $9 million, respectively. If Vegan Silk adoption continues to accelerate, these numbers could mark just the beginning of Bolt's growth trajectory. Is BSLK a Good Stock to Buy? Turning to Wall Street, analysts have a Hold consensus rating on BSLK stock based on one Hold recommendation. Furthermore, the average Bolt Projects stock price target of $2.50 per share implies a downside of over 80% from the current level.
Yahoo
8 hours ago
- Yahoo
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.46 per share versus the Zacks Consensus Estimate of a loss of $6.4. This compares to a loss of $11.2 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +30.31%. A quarter ago, it was expected that this company would post a loss of $6.8 per share when it actually produced a loss of $5.8, delivering a surprise of +14.71%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Bolt Biotherapeutics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.8 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 73.46%. This compares to year-ago revenues of $1.27 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Bolt Biotherapeutics shares have lost about 47.5% since the beginning of the year versus the S&P 500's gain of 10%. What's Next for Bolt Biotherapeutics? While Bolt Biotherapeutics has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Bolt Biotherapeutics was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$5.70 on $0.9 million in revenues for the coming quarter and -$23.00 on $4.02 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the bottom 41% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the broader Zacks Medical sector, Electromed, Inc. (ELMD), is yet to report results for the quarter ended June 2025. The results are expected to be released on August 26. This company is expected to post quarterly earnings of $0.22 per share in its upcoming report, which represents a year-over-year change of +10%. The consensus EPS estimate for the quarter has been revised 5% higher over the last 30 days to the current level. Electromed, Inc.'s revenues are expected to be $16.51 million, up 11.3% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bolt Biotherapeutics, Inc. (BOLT) : Free Stock Analysis Report Electromed, Inc. (ELMD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research